About Axiom
Axiom is building the closed-loop scientific AI system required to replace animal testing and, over time, much of human safety testing. We start with pharma’s hardest drug development toxicology problems. Those problems define the proprietary human biological data we generate through Axiom’s Data Factory. We use that data to train scientific AI, partnering with leading AI labs to improve frontier models while building our own specialist agentic harness to deploy the improved frontier models back into pharma. Each deployment reveals the next capabilities to build, creating a compounding loop across data, models, and drug development. Today, liver toxicity is our proving ground. Axiom is already helping leading pharmaceutical companies understand toxicity, identify its mechanism, and design safer drugs. Over time, we will expand across the major organ systems and build the experimental and agentic system of record for translational drug development. Our goal is to dramatically reduce the risk of testing new molecules in humans, enabling high throughput evaluation of efficacy in humans.
What You Will Do
You will own the commercial strategy and operations.
You will:
Work with the founders and team to map the people and phased progression strategy for every major account including top pharmaceuticals and AI research labs
Own pilot operational execution and pilot-to-revenue conversion across Axiom’s commercial pipeline
Partner closely with the CEO and technical leadership to turn customer excitement into durable enterprise adoption for companies ranging in size from $100B to over $1T
Chart the course for major accounts going from 6 figures to 7 figures to 8 figures and beyond
Build relationships across scientific, technical, business, legal, procurement, and executive teams
Build and run a rigorous commercial operating system: pipeline management, forecasting, pricing, packaging, deal strategy, and expansion
Act as the voice of the customer inside Axiom, bringing energy, urgency, debate, and insight from the field back into product, roadmap, and company direction
Drive creative dealmaking across SaaS, platform licenses, strategic research collaborations, drug discovery partnerships, and data relationships
Partner with the CEO as a true counterpart, shaping strategy, refining company direction, and pushing decisions through high conviction, intense debate
Be deeply present in person, in the office, with customers, and at conferences build deep relationships with all parts of the organizations to drive customer outcomes
Handle all the dirty work and operations by pushing deals through legal, procurement, and IT while also ensuring the Axiom team is executing flawlessly
Help ensure the trains run on time internally across the highest priority customer and company initiatives
What We Are Looking For
A world-class operator with a strong commercial, operations, and strategy background with a track record of driving complex enterprise relationships to real revenue
Deep understanding of pharma and biotech, including discovery workflows, toxicology, DMPK, and how large organizations evaluate and adopt new platforms
Exceptional at customer management, commercial strategy, and internal coordination / operations
Works extremely hard and sees their work as being a major part of their identity.
Strong product instinct and customer empathy with a natural ability to bring customer needs back into the company
Deep, innate curiosity for the science and software
Highly intelligent, highly energetic, highly persuasive, and highly ambitious.
Able to hold conversations with some of the most successful drug hunters and AI researchers in the world
Strong technical chops Able to fluently and credibly discuss AI, scientific product vision, and business strategy with customers, executives, and internal technical teams.
Creative dealmaker who can structure non-obvious partnerships and get difficult deals done
Strong operator who can introduce rigor, accountability, and clarity without creating bureaucracy.
Comfortable pushing back on the CEO and leadership team with sharp, well-thought opinions.
Thrives in an intense, high expectation, in person, honest, blunt environment.
Based in San Francisco, with regular travel to customers and conferences.
Skills Required
- Strong commercial, operations, and strategy background with track record driving complex enterprise relationships to revenue
- Deep understanding of pharma and biotech, including discovery workflows, toxicology, and DMPK
- Exceptional customer management, commercial strategy, and internal coordination/operations skills
- Strong product instinct and customer empathy; bring customer needs into product and roadmap
- Ability to fluently and credibly discuss AI, scientific product vision, and business strategy with technical and executive stakeholders
- Proven creative dealmaking skills to structure complex partnerships and close difficult deals
- Experience managing pilots, pilot-to-revenue conversion, pricing, packaging, pipeline management, and forecasting
- Willingness to be deeply present in person, based in San Francisco, with regular travel to customers and conferences
- Ability to work intensely, high ownership mentality, and thrive in a high-expectation, blunt environment
- Strong operator who can introduce rigor, accountability, and clarity without creating bureaucracy
- Comfortable pushing back on the CEO and leadership team with well-reasoned opinions
- Able to build relationships across scientific, technical, business, legal, procurement, and executive teams
What We Do
Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousands of molecules with curated clinical outcome data. Axiom's AI models offer higher accuracy than advanced in vitro systems like 3d spheroids, deep mechanistic understanding which untangles mitochondrial toxicity, ER stress, ROS formation, cytotoxicity, and more, and precise risk assessment for any molecule at relevant clinical dosage and clinical exposure levels. Our models remove the need for costly physical experiments, giving more accurate and cheaper toxicity assessments, and empowering scientists to make better-informed decisions and bring safer drugs to the clinic.
.png)
